UNSPSC 51343008: Nevirapine hemihydrate

This classification denotes a reverse transcriptase inhibitor with the molecular formula 2C15H14N4O.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B7XF2TD73C. European Medicines Agency schedules nevirapine hemihydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB34149. Most nations, for tariff and trade purposes, schedule nevirapine hemihydrate under HS 29339940 and SITC 51577. As of Q4 2014, NEVIRAPINE HEMIHYDRATE remains US FDA's Preferred Term for this commodity.

SMILES: CC1CCNC2C1NC(=O)C3CCCNC3N2C4CC4.CC1CCNC2C1NC(=O)C3CCCNC3N2C4CC4.O.

UNSPSC 51343008 Nevirapine hemihydrate is a Commodity code for a specific antiretroviral pharmaceutical active ingredient, but the recent state and local opportunities tagged under this code do not reflect procurement of nevirapine hemihydrate itself. Instead, the opportunities show purchases of unrelated pharmaceutical products — doxycycline hyclate, ciprofloxacin hydrochloride, and naloxone — suggesting a mismatch between the code assignment and the actual work being solicited. State and local health departments and counties are using this code tag for pharmaceutical procurement more broadly, including antibiotics, emergency medications, and drug-disposal systems acquired through standard competitive bidding processes (IFB, piggyback consortium purchasing) and delivered on fixed-fee contracts with renewal options.

Geographic activity is limited in the recent record to Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, for doxycycline hyclate and ciprofloxacin hydrochloride with a 12-month initial term and two renewal years. Seminole County, Florida released an IFB on June 30, 2026, for 1,900 units of naloxone and 800 safe drug-deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the bid response deadline was July 26, 2023 (a historical date that predates the posting). Given the code-to-opportunity mismatch and the sparse recent record, this code shows little relevant current activity for procurement professionals targeting state and local health-sector pharmaceutical buys under its nominal scope.